BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | -99.5% | 3 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $4,971 | -0.6% | 433 | -0.7% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | 0.0% | 436 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | -61.5% | 430 | -47.0% | 0.00% | -50.0% |
| Q1 2022 | $13,000 | +18.2% | 811 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | +22.2% | 811 | +27.9% | 0.00% | +100.0% |
| Q3 2021 | $9,000 | +350.0% | 634 | +331.3% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 147 | -25.8% | 0.00% | -100.0% |
| Q1 2021 | $2,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |